MaraƱon, Araceli G.

HRN: 23 71 82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/20/2023
09/27/2023
IV
2.25g
Q6
CAP-HR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: